{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:21Z","timestamp":1793978841155,"version":"4.8.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473782"],"award-info":[{"award-number":["82473782"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574261"],"award-info":[{"award-number":["82574261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503015"],"award-info":[{"award-number":["82503015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1624"],"award-info":[{"award-number":["2025ZNSFSC1624"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC0694"],"award-info":[{"award-number":["2025ZNSFSC0694"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC0762"],"award-info":[{"award-number":["2024NSFSC0762"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2025ZNSFSC1869"],"award-info":[{"award-number":["2025ZNSFSC1869"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772308"],"award-info":[{"award-number":["2025M772308"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejmech.2026.119253","type":"journal-article","created":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:35:46Z","timestamp":1786880146000},"page":"119253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Small-molecule inhibitors of SGK1: Structural basis, structure-activity relationships, and therapeutic perspectives"],"prefix":"10.1016","volume":"319","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2223-3091","authenticated-orcid":false,"given":"Jingjing","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guonian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghong","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119253_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1036844","article-title":"Serum and glucocorticoid-regulated kinase 1: structure, biological functions, and its inhibitors","volume":"13","author":"Jang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib2","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1152\/physrev.00050.2005","article-title":"Patho)physiological significance of the Serum- and glucocorticoid-inducible kinase isoforms","volume":"86","author":"Lang","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2026.119253_bib3","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1074\/jbc.M807502200","article-title":"Regulation of a third conserved phosphorylation site in SGK1","volume":"284","author":"Chen","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2016.06.004","article-title":"PDK1-SGK1 signaling sustains AKT-independent mTORC1 activation and confers resistance to PI3K\u03b1 inhibition","volume":"30","author":"Castel","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119253_bib5","first-page":"49","article-title":"The dark side of PI3K signaling","volume":"123","author":"Di","year":"2017","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.ejmech.2026.119253_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/BJ20130342","article-title":"Elevated SGK1 predicts resistance of breast cancer cells to Akt inhibitors","volume":"452","author":"Sommer","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119253_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1172\/JCI31538","article-title":"Salt, sodium channels, and SGK1","volume":"117","author":"Pearce","year":"2007","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119253_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110778","article-title":"SGK1 is necessary to FoxO3a negative regulation, oxidative stress and cardiac fibroblast activation induced by TGF-\u03b21","volume":"109","author":"Gonz\u00e1lez-Herrera","year":"2023","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2026.119253_bib9","doi-asserted-by":"crossref","DOI":"10.1080\/14756366.2025.2546591","article-title":"Discovery of a brain penetrant SGK1 inhibitor using a ligand- and structure-based virtual screening methodology","volume":"40","author":"Madruga","year":"2025","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib10","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1016\/j.bmcl.2009.05.051","article-title":"Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1 (SGK1) inhibitors","volume":"19","author":"Hammond","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119253_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000331722","article-title":"EMD638683, a novel SGK inhibitor with antihypertensive potency","volume":"28","author":"Ackermann","year":"2011","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/acs.jmedchem.1c01601","article-title":"Rational design of highly potent, selective, and bioavailable SGK1 protein kinase inhibitors for the treatment of osteoarthritis","volume":"65","author":"Halland","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib13","series-title":"Amino-Substituted Pyrrolotriazine Derivatives as Inhibitors of sgk1","author":"Glunz","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119253_bib14","series-title":"Piperidine Substituted Pyrazolopyrimidine Derivatives as Inhibitors of Sgk1","author":"Maishal","year":"2025"},{"key":"10.1016\/j.ejmech.2026.119253_bib15","series-title":"Pyrazolo[3,4-d]pyrimidin-6-yl-sulfonamide Derivatives for the Inhibition of sgk-1 and Treatment of Cancer","author":"Maguire","year":"2024"},{"key":"10.1016\/j.ejmech.2026.119253_bib16","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.hrthm.2025.03.153","article-title":"PE-499663-003 SGK-1 inhibition with LQT-1213 significantly reduces the qtcf in patients with congenital long QT syndrome in the WAVE I, part 2 study","volume":"22","author":"Sager","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejmech.2026.119253_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.608722","article-title":"SGK1 in human cancer: emerging roles and mechanisms","volume":"10","author":"Sang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119253_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000070244","article-title":"Stimulus-dependent regulation of serum and glucocorticoid inducible protein kinase (SGK) transcription, subcellular localization and enzymatic activity","volume":"13","author":"Firestone","year":"2003","journal-title":"Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib19","doi-asserted-by":"crossref","first-page":"6180","DOI":"10.3748\/wjg.v21.i20.6180","article-title":"SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK\/ERK\/p53 pathway in colitis","volume":"21","author":"Bai","year":"2015","journal-title":"World J. Gastroenterol. WJG"},{"key":"10.1016\/j.ejmech.2026.119253_bib20","unstructured":"SGK1 serum\/glucocorticoid regulated kinase 1 [Homo sapiens (human)]. Gene, NCBI. https:\/\/www.ncbi.nlm.nih.gov\/gene\/6446 (accessed December 19, 2025)."},{"key":"10.1016\/j.ejmech.2026.119253_bib21","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj3440189","article-title":"Characterization of the structure and regulation of two novel isoforms of serum- and glucocorticoid-induced protein kinase","volume":"344","author":"Kobayashi","year":"1999","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119253_bib22","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1110\/ps.073161707","article-title":"Crystal structure of the kinase domain of serum and glucocorticoid-regulated kinase 1 in complex with AMP PNP","volume":"16","author":"Zhao","year":"2007","journal-title":"Protein Sci. Publ. Protein Soc."},{"key":"10.1016\/j.ejmech.2026.119253_bib23","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.apsb.2018.07.001","article-title":"Serum and glucocorticoid inducible protein kinases (SGKs): a potential target for cancer intervention","volume":"8","author":"Basnet","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.119253_bib24","first-page":"21","article-title":"Crystal structure of an inactive Akt2 kinase domain","volume":"11","author":"Huang","year":"2003","journal-title":"Struct. Lond. Engl."},{"key":"10.1016\/j.ejmech.2026.119253_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/08977194.2010.518616","article-title":"Second AKT: the rise of SGK in cancer signalling","volume":"28","author":"Bruhn","year":"2010","journal-title":"Growth Factors Chur Switz"},{"key":"10.1016\/j.ejmech.2026.119253_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/ph13110413","article-title":"Serum and glucocorticoid-inducible kinase 1 (SGK1) in NSCLC therapy","volume":"13","author":"Guerriero","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2026.119253_bib27","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1091\/mbc.e06-10-0968","article-title":"Multiple translational isoforms give functional specificity to serum- and glucocorticoid-induced kinase 1","volume":"18","author":"Arteaga","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2026.119253_bib28","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1111\/j.1742-4658.2006.05304.x","article-title":"A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway","volume":"273","author":"Bogusz","year":"2006","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2026.119253_bib29","doi-asserted-by":"crossref","first-page":"39905","DOI":"10.1074\/jbc.M110.161133","article-title":"Glucocorticoid-induced leucine zipper 1 stimulates the epithelial sodium channel by regulating Serum- and glucocorticoid-induced kinase 1 stability and subcellular localization","volume":"285","author":"Soundararajan","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib30","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1161\/01.CIR.0000118538.21306.A9","article-title":"Inhibitors of protein kinase signaling pathways","volume":"109","author":"Force","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ejmech.2026.119253_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102247","article-title":"Structural features of the protein kinase domain and targeted binding by small-molecule inhibitors","volume":"298","author":"Arter","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib32","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2174\/138955708786141043","article-title":"Strategies for the design of selective protein kinase inhibitors","volume":"8","author":"Sawa","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib33","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/molecules26030651","article-title":"Druggable transient pockets in protein kinases","volume":"26","author":"Umezawa","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.119253_bib34","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1042\/BST20190777","article-title":"Inhibitors in AKTion: ATP-Competitive vs allosteric","volume":"48","author":"Lazaro","year":"2020","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2026.119253_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128725","article-title":"The role of serum and glucocorticoid-regulated kinase 1 in cellular signaling: implications for drug development","volume":"258","author":"Gulzar","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejmech.2026.119253_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biochi.2019.07.007","article-title":"Computational insights into the active structure of SGK1 and its implication for ligand design","volume":"165","author":"Akhoon","year":"2019","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2026.119253_bib37","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3390\/cancers14102385","article-title":"SGK1 in cancer: Biomarker and drug target","volume":"14","author":"Cicenas","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.119253_bib38","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1042\/BJ20081668","article-title":"mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)","volume":"416","author":"Garc\u00eda-Mart\u00ednez","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2026.119253_bib39","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/s41388-020-01433-6","article-title":"Serum- and glucocorticoid- inducible kinase 2, SGK2, is a novel autophagy regulator and modulates platinum drugs response in cancer cells","volume":"39","author":"Ranzuglia","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.119253_bib40","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920940946","article-title":"The prospect of serum and glucocorticoid-inducible kinase 1 (SGK1) in cancer therapy: a rising star","volume":"12","author":"Zhu","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.119253_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1242\/jcs.077503","article-title":"Serine\/threonine protein kinase SGK1 in glucocorticoid-dependent transdifferentiation of pancreatic acinar cells to hepatocytes","volume":"124","author":"Wallace","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2026.119253_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.00826","article-title":"The emerging role of SGK1 (Serum- and glucocorticoid-regulated kinase 1) in major depressive disorder: hypothesis and mechanisms","volume":"11","author":"Dattilo","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.ejmech.2026.119253_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15698\/cst2019.01.170","article-title":"Serum- and glucocorticoid-inducible kinase 1 and the response to cell stress","volume":"3","author":"Lang","year":"2019","journal-title":"Cell Stress"},{"key":"10.1016\/j.ejmech.2026.119253_bib44","doi-asserted-by":"crossref","first-page":"E971","DOI":"10.1152\/ajpendo.00021.2002","article-title":"Glucocorticoids stimulate human sgk1 gene expression by activation of a GRE in its 5\u2019-flanking region","volume":"283","author":"Itani","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.119253_bib45","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/MNH.0b013e32832f125e","article-title":"The physiological impact of the Serum- and glucocorticoid-inducible kinase SGK1","volume":"18","author":"Lang","year":"2009","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejmech.2026.119253_bib46","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1096\/fj.12-218230","article-title":"Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1","volume":"27","author":"Lang","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmech.2026.119253_bib47","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1038\/sj.cdd.4402227","article-title":"Serum\/glucocorticoid-induced protein kinase-1 facilitates androgen receptor-dependent cell survival","volume":"14","author":"Shanmugam","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejmech.2026.119253_bib48","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00109-007-0205-2","article-title":"IL-2 signals through Sgk1 and inhibits proliferation and apoptosis in kidney cancer cells","volume":"85","author":"Amato","year":"2007","journal-title":"J. Mol. Med. Berl. Ger."},{"key":"10.1016\/j.ejmech.2026.119253_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/pros.21416","article-title":"Serum\/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers","volume":"72","author":"Szmulewitz","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.ejmech.2026.119253_bib50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.4331\/wjbc.v5.i3.346","article-title":"FoxO3a and disease progression","volume":"5","author":"Nho","year":"2014","journal-title":"World J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib51","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1210\/me.2009-0265","article-title":"Serum- and glucocorticoid-inducible kinase 1 (SGK1) regulates adipocyte differentiation via Forkhead Box O1","volume":"24","author":"Di Pietro","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.119253_bib52","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2147\/DDDT.S494841","article-title":"The roles of Forkhead Box O3a (FOXO3a) in bone and cartilage diseases \u2013 a narrative review","volume":"19","author":"Wu","year":"2025","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2026.119253_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.232","article-title":"SGK-1 protects kidney cells against apoptosis induced by ceramide and TNF-\u03b1","volume":"6","author":"Pastore","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119253_bib54","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/bjc.2017.293","article-title":"SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway","volume":"117","author":"Liu","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119253_bib55","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fphys.2012.00212","article-title":"Nedd4-2 and the regulation of epithelial sodium transport","volume":"3","author":"Rotin","year":"2012","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ejmech.2026.119253_bib56","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1093\/emboj\/20.24.7052","article-title":"Phosphorylation of Nedd4-2 by Sgk1 regulates epithelial Na+ channel cell surface expression","volume":"20","author":"Debonneville","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2026.119253_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1476030","article-title":"NF-\u03baB signaling pathway in tumor microenvironment","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2026.119253_bib58","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fonc.2020.01221","article-title":"The role of GSK3\u03b2 in T lymphocytes in the tumor microenvironment","volume":"10","author":"Dimou","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2026.119253_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102036","article-title":"SGK1 negatively regulates inflammatory immune responses and protects against alveolar bone loss through modulation of TRAF3 activity","volume":"298","author":"Han","year":"2022","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.celrep.2019.02.111","article-title":"PI3K inhibition activates SGK1 via a feedback loop to promote chromatin-based regulation of ER-Dependent gene expression","volume":"27","author":"Toska","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2026.119253_bib61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1152\/physiol.00053.2004","article-title":"SGK1: a rapid aldosterone-induced regulator of renal sodium reabsorption","volume":"20","author":"McCormick","year":"2005","journal-title":"Physiology"},{"key":"10.1016\/j.ejmech.2026.119253_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100919","article-title":"In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate","volume":"297","author":"Pokorny","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib63","doi-asserted-by":"crossref","first-page":"23978","DOI":"10.1074\/jbc.M604333200","article-title":"Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated Kinase-3","volume":"281","author":"Tessier","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib64","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1158\/0008-5472.CAN-17-2105","article-title":"SGK1 is a critical component of an AKT-independent pathway essential for PI3K-mediated tumor development and maintenance","volume":"77","author":"Orlacchio","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119253_bib65","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.3390\/ijms23158635","article-title":"Identification of novel inhibitors targeting SGK1 via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.119253_bib66","article-title":"Identification of a new structural family of SGK1 inhibitors as potential neuroprotective agents","volume":"38","author":"Maestro","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib67","doi-asserted-by":"crossref","first-page":"7475","DOI":"10.1158\/0008-5472.CAN-08-1047","article-title":"Development of a small molecule serum and glucocorticoid-regulated kinase 1 antagonist and its evaluation as a prostate cancer therapeutic","volume":"68","author":"Sherk","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119253_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136143","article-title":"Inhibition of serum and glucocorticoid regulated kinases by GSK650394 reduced infarct size in early cerebral ischemia-reperfusion with decreased BBB disruption","volume":"762","author":"Chi","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2026.119253_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104462","article-title":"Bioanalytical method validation, biopharmaceutical and pharmacokinetic evaluation of GSK-650394, a serum- and glucocorticoid-regulated kinase 1 inhibitor","volume":"16","author":"Le","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/ml5003376","article-title":"Discovery of N-[4-(1H-Pyrazolo[3,4-b]pyrazin-6-yl)-phenyl]-sulfonamides as highly active and selective SGK1 inhibitors","volume":"6","author":"Halland","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119253_bib71","series-title":"N-[4-(1H-PYRAZOLO[3,4-b]PYRAZIN-6-YL)-PHENYL]-SULFONAMIDES AND THEIR USE AS PHARMACEUTICALS","author":"Nazare","year":"2013"},{"key":"10.1016\/j.ejmech.2026.119253_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117336","article-title":"Hit to lead optimization of the 4-trifluoromethylquinoline derivatives as novel SGK1 inhibitors with potent anti-prostate cancer activity","volume":"287","author":"Li","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib73","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1007\/s11030-025-11181-y","article-title":"Correction: discovery of novel 4-trifluoromethyl-2-anilinoquinoline derivatives as potential anti-cancer agents targeting SGK1","volume":"29","author":"Xu","year":"2025","journal-title":"Mol. Divers."},{"key":"10.1016\/j.ejmech.2026.119253_bib74","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1159\/000374008","article-title":"SI113, a specific inhibitor of the Sgk1 kinase activity that counteracts cancer cell proliferation","volume":"35","author":"D'Antona","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2026.119253_bib75","doi-asserted-by":"crossref","first-page":"15868","DOI":"10.18632\/oncotarget.7520","article-title":"SI113, a SGK1 inhibitor, potentiates the effects of radiotherapy, modulates the response to oxidative stress and induces cytotoxic autophagy in human glioblastoma multiforme cells","volume":"7","author":"Talarico","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.119253_bib76","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1002\/jcp.25850","article-title":"The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells","volume":"232","author":"Conza","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejmech.2026.119253_bib77","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.tranon.2019.05.008","article-title":"Preclinical model of ovarian cancer, the SGK1 inhibitor SI113 counteracts the development of paclitaxel resistance and restores drug sensitivity","volume":"12","author":"D'Antona","year":"2019","journal-title":"Transl. Oncol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.119253_bib78","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1021\/acs.jmedchem.5c03050","article-title":"Brain permeable SGK1 inhibitors: a promising therapeutic strategy for neurodegenerative diseases","volume":"69","author":"Madruga","year":"2026","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib79","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acsmedchemlett.5c00217","article-title":"Novel piperidine substituted pyrazolopyrimidine derivatives as SGK1 inhibitors for treating cardiovascular diseases","volume":"16","author":"Sabnis","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.119253_bib80","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41598-017-00413-3","article-title":"Inhibition of serum and glucocorticoid regulated kinase-1 as novel therapy for cardiac arrhythmia disorders","volume":"7","author":"Bezzerides","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119253_bib81","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.hrthm.2022.12.036","article-title":"SGK1 inhibition attenuates the action potential duration in reengineered heart cell models of drug-induced QT prolongation","volume":"20","author":"Kim","year":"2023","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.ejmech.2026.119253_bib82","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.hroo.2023.02.003","article-title":"SGK1 inhibition attenuated the action potential duration in patient- and genotype-specific re-engineered heart cells with congenital long QT syndrome","volume":"4","author":"Kim","year":"2023","journal-title":"Heart Rhythm O2"},{"key":"10.1016\/j.ejmech.2026.119253_bib83","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1039\/b923848b","article-title":"Protein kinase inhibition of clinically important staurosporine analogues","volume":"27","author":"Gani","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2026.119253_bib84","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1177\/24725552211002465","article-title":"Identification and kinetic characterization of Serum- and glucocorticoid-regulated kinase inhibitors using a fluorescence polarization\u2013based assay","volume":"26","author":"Kim","year":"2021","journal-title":"SLAS Discov."},{"key":"10.1016\/j.ejmech.2026.119253_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173361","article-title":"Discovery of a novel small molecule PT109 with multi-targeted effects against Alzheimer's disease in vitro and in vivo","volume":"883","author":"Chen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174837","article-title":"PT109, a novel multi-kinase inhibitor suppresses glioblastoma multiforme through cell reprogramming: involvement of PTBP1\/PKM1\/2 pathway","volume":"920","author":"Yang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib87","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/bph.14926","article-title":"PO-322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity","volume":"177","author":"Lai","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.119253_bib88","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.7150\/jca.19566","article-title":"Development of a new analog of SGK1 inhibitor and its evaluation as a therapeutic molecule of colorectal cancer","volume":"8","author":"Liang","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.ejmech.2026.119253_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111675","article-title":"Review about the multi-target profile of resveratrol and its implication in the SGK1 inhibition","volume":"183","author":"Catalogna","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119253_bib90","article-title":"A G-quadruplex nanoswitch in the SGK1 promoter regulates isoform expression by K+\/Na+ balance and resveratrol binding","volume":"1865","author":"Chen","year":"2021","journal-title":"Biochim. Biophys. Acta BBA - Gen. Subj."},{"key":"10.1016\/j.ejmech.2026.119253_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078019","article-title":"Resveratrol inhibits the epithelial sodium channel via phopshoinositides and AMP-activated protein kinase in kidney collecting duct cells","volume":"8","author":"Weixel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119253_bib92","article-title":"Discovery of herbacetin as a novel SGK1 inhibitor to alleviate myocardial hypertrophy","volume":"9","author":"Zhang","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejmech.2026.119253_bib93","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2147\/JAA.S468689","article-title":"Herbacetin inhibits asthma development by blocking the SGK1\/NF-\u03baB signaling pathway","volume":"17","author":"Chen","year":"2024","journal-title":"J. Asthma Allergy"},{"key":"10.1016\/j.ejmech.2026.119253_bib94","article-title":"Multi-scale discovery of herbacetin as a macrophage-targeted SGK1-STAT1 signaling inhibitor alleviating lung inflammation and barrier dysfunction","volume":"148","author":"Ge","year":"2025","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.ejmech.2026.119253_bib95","first-page":"1","article-title":"Contemporary design of small-molecule kinase modulators: orthosteric, allosteric and induced-proximity strategies","author":"Rudolph","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119253_bib96","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1021\/acschembio.9b00505","article-title":"Design and characterization of SGK3-PROTAC1, an isoform specific SGK3 kinase PROTAC degrader","volume":"14","author":"Tovell","year":"2019","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119253_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2026.104650","article-title":"AI agents in drug discovery: applications and case studies","author":"Huynh","year":"2026","journal-title":"Drug Discov. Today"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426006987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:00:11Z","timestamp":1793977211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426006987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":97,"alternative-id":["S0223523426006987"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119253","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small-molecule inhibitors of SGK1: Structural basis, structure-activity relationships, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119253","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119253"}}